A recent Radiology journal study assesses the power of a fully automated deep learning (DL) model to produce deterministic outputs for identifying clinically significant prostate cancer (csPCa). Study ...
An open-label, phase I trial of the SIRPα monoclonal antibody, BI 770371, alone and in combination with the PD-1 inhibitor ezabenlimab in patients with advanced solid tumors. This is an ASCO Meeting ...
Deep learning (DL) is a type of artificial intelligence (AI) that utilizes artificial neural networks (ANNs) to process data through two or more layers, each of which can recognize complex features of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback